Interleukin-6 as a biomarker in patients with hepatobiliary cancers

BACKGROUND: The role of inflammation has been well established in many cancers, including hepatobiliary cancers. Elevated levels of interleukin-6 (IL-6), a pro-inflammatory marker, are associated with poor overall survival (OS) in hepatocellular carcinoma (HCC) patients. METHODS: We performed a stud...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Gastrointest Oncol
Autori principali: Gosain, Rohit, Anwar, Sidra, Miller, Austin, Iyer, Renuka, Mukherjee, Sarbajit
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534725/
https://ncbi.nlm.nih.gov/pubmed/31183205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2019.01.09
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi